NCT01277627View on ClinicalTrials.gov

Influence of Nevirapine on HCV Viral Load

NAUnknownINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

July 31, 2012

Conditions

HCV Infection.HCV Viral Load.

Interventions

DRUG

Nevirapine

nevirapine: 400 mg a day.

DRUG

efavirenz, protease inhibitors

efavirenz: 600 mg a day

Trial Locations (1)

41014

Valme University Hospital, Seville

Sponsors

Collaborators (1)

Boehringer Ingelheim

All Listed Sponsors

collaborator

Boehringer Ingelheim

INDUSTRY

lead

Valme University Hospital

OTHER

NCT01277627 - Influence of Nevirapine on HCV Viral Load | Biotech Hunter | Biotech Hunter